2024
Reactive axillary lymph nodes after COVID-19 mRNA vaccination: comparison of mRNA vs. attenuated whole-virus vaccines
Adin M, Isufi E, Wu J, Pang Y, Nguyen D, Has D, Caner C, Aboueldaha N, Mossa-Basha M, Pucar D. Reactive axillary lymph nodes after COVID-19 mRNA vaccination: comparison of mRNA vs. attenuated whole-virus vaccines. Nuclear Medicine Communications 2024, 45: 474-480. PMID: 38465449, DOI: 10.1097/mnm.0000000000001833.Peer-Reviewed Original ResearchAxillary lymph nodesWhole virus vaccineLymph nodesMRNA vaccinesNatural courseValue of clinical parametersCOVID-19 mRNA vaccinesPredictive value of clinical parametersDose of vaccine administrationPET-CT studiesCohort of oncology patientsDeauville criteriaPET criteriaClinical parametersYounger patientsSingle doseModerna recipientsJ&J vaccinePET-positiveMultivariate analysisVaccine typesOncology patientsPredictive valueVaccine administrationModerna vaccine
2021
Clinical PET/CT utilization during the COVID-19 pandemic: initial experience at Yale University
Adin ME, Uezono H, Isufi E, Pang Y, Zucconi W, Saperstein L, Pucar D. Clinical PET/CT utilization during the COVID-19 pandemic: initial experience at Yale University. Nuclear Medicine Communications 2021, 42: 1277-1284. PMID: 34049340, PMCID: PMC8527913, DOI: 10.1097/mnm.0000000000001445.Peer-Reviewed Original ResearchConceptsCT utilizationOncologic factorsPET/CT scanningTertiary academic centerPET-CT scanCOVID-19COVID-19 pandemicElectronic medical recordsPublic health recordsScan positivityYounger patientsOncologic dataCOVID-19 casesEpidemiologic trendsHematologic malignanciesMedical recordsEpidemiologic changesSolid cancersCase volumeAcademic centersInitial experienceCT scanningCancer typesHealth recordsPandemic relative